- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01581983
Mindfulness Meditation Format Pilot Study
July 9, 2015 updated by: Helane Wahbeh, Oregon Health and Science University
The purpose of this study is to assess feasibility of an internet and individual format of mindfulness meditation in people with posttraumatic stress disorder (PTSD) and depression symptoms
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Internet and individual formats of mindfulness meditation have not been previously evaluated.
In order establish feasibility of such formats a pilot study is need.
The current study will randomize up to 20 people with PTSD and depression symptoms and evaluate changes in PTSD and depression symptoms from before to after the internet and individual mindfulness meditation interventions.
Study Type
Interventional
Enrollment (Actual)
8
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97239
- Oregon Health & Science University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Good general health
- Age 25-65
- Access to internet
- PTSD symptoms (score >14 on PTSD screen)
- Depression symptoms (endorsement of one question on depression screen)
- Stable on medications six weeks prior to the study
- Willing to be stable on medications during study
Exclusion Criteria:
- Significant potentially life-limiting acute medical illness
- Risk for suicide
- >2 drinks/day of alcohol and street drug use besides marijuana
- Current daily meditation practice
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Internet Mindfulness Meditation
|
one hour session each week for six weeks
|
Experimental: Individual Mindfulness Meditation
|
one hour session each week for six weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Posttraumatic Stress Disorder Checklist
Time Frame: Change from baseline to week 7.
|
The Posttraumatic Stress Disorder Checklist will be administered immediately before their first intervention session and within one week of their last intervention session.
The primary outcome is the change in score on this instrument from baseline to week 7.
|
Change from baseline to week 7.
|
Beck Depression Inventory
Time Frame: Change from Baseline to Week 7
|
The Beck Depression Inventory will be administered immediately before their first intervention session and within one week of their last intervention session.
The primary outcome is the change in score on this instrument from baseline to week 7.
|
Change from Baseline to Week 7
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2012
Primary Completion (Actual)
June 1, 2015
Study Completion (Actual)
June 1, 2015
Study Registration Dates
First Submitted
April 7, 2012
First Submitted That Met QC Criteria
April 18, 2012
First Posted (Estimate)
April 20, 2012
Study Record Updates
Last Update Posted (Estimate)
July 13, 2015
Last Update Submitted That Met QC Criteria
July 9, 2015
Last Verified
July 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00008355
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Internet Mindfulness Meditation
-
Oregon Health and Science UniversityCompleted
-
University of California, San FranciscoAmerican Society of HematologyCompletedChronic Myeloid Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Myeloproliferative NeoplasmUnited States
-
University Hospital, AngersNot yet recruitingLateral Sclerosis Amyotrophy | Mindfulness Meditation
-
University of Illinois at Urbana-ChampaignNorthwestern University Feinberg School of Medicine; Southern Illinois University and other collaboratorsNot yet recruitingPain, Postoperative | Depression, Unipolar
-
Barbara L. Fredrickson, PhDNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Universiti Tunku Abdul RahmanRecruiting
-
Icahn School of Medicine at Mount SinaiSuspendedPain, Postoperative | Spine Surgery | MeditationUnited States
-
York UniversityCompletedChronic Pain | Depression, AnxietyCanada
-
Jordan University of Science and TechnologyCompletedChronic Kidney Diseases | Hemodialysis ComplicationJordan
-
Kaiser PermanenteCompletedDepression | Anxiety | Advanced CancerUnited States